Avid Bioservices Inc (CDMO)
6.82
+0.15
(+2.25%)
USD |
NASDAQ |
Apr 24, 16:00
6.82
0.00 (0.00%)
After-Hours: 20:00
Avid Bioservices Cash and Short Term Investments (Quarterly): 31.42M for Oct. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
October 31, 2023 | 31.42M |
July 31, 2023 | 24.90M |
April 30, 2023 | 38.54M |
January 31, 2023 | 59.92M |
October 31, 2022 | 77.29M |
July 31, 2022 | 115.14M |
April 30, 2022 | 126.17M |
January 31, 2022 | 149.96M |
October 31, 2021 | 163.68M |
July 31, 2021 | 159.69M |
April 30, 2021 | 169.92M |
January 31, 2021 | 70.89M |
October 31, 2020 | 35.66M |
July 31, 2020 | 28.21M |
April 30, 2020 | 36.26M |
January 31, 2020 | 30.69M |
October 31, 2019 | 33.96M |
July 31, 2019 | 28.94M |
April 30, 2019 | 32.35M |
January 31, 2019 | 27.76M |
October 31, 2018 | 32.69M |
July 31, 2018 | 37.48M |
April 30, 2018 | 42.26M |
January 31, 2018 | 17.94M |
October 31, 2017 | 27.73M |
Date | Value |
---|---|
July 31, 2017 | 37.26M |
April 30, 2017 | 46.80M |
January 31, 2017 | 41.53M |
October 31, 2016 | 49.06M |
July 31, 2016 | 44.20M |
April 30, 2016 | 61.41M |
January 31, 2016 | 67.47M |
October 31, 2015 | 72.00M |
July 31, 2015 | 59.02M |
April 30, 2015 | 68.00M |
January 31, 2015 | 55.24M |
October 31, 2014 | 64.44M |
July 31, 2014 | 73.26M |
April 30, 2014 | 77.49M |
January 31, 2014 | 63.18M |
October 31, 2013 | 44.44M |
July 31, 2013 | 41.60M |
April 30, 2013 | 35.20M |
January 31, 2013 | 26.26M |
October 31, 2012 | 24.44M |
July 31, 2012 | 18.99M |
April 30, 2012 | 18.03M |
January 31, 2012 | 19.76M |
October 31, 2011 | 18.06M |
July 31, 2011 | 16.54M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
24.90M
Minimum
Jul 2023
169.92M
Maximum
Apr 2021
74.40M
Average
38.54M
Median
Apr 2023
Cash and Short Term Investments (Quarterly) Benchmarks
Emergent BioSolutions Inc | 111.70M |
Creative Medical Technology Holdings Inc | 9.987M |
Viking Therapeutics Inc | 362.08M |
Stereotaxis Inc | 19.82M |
MAIA Biotechnology Inc | 7.151M |